Australia's largest stock trading and investment forum Australia's #1 stock forum

SRX

Click for more information

0.00%

17.5¢ sierra rutile holdings limited

Ann: SARAH Clinical Study Results Investor Presentation, page-30

First 30 Last

Share
Profile

Follow
PatienceToWin

13,164 Posts.

1133

24/04/17

10:50

Post #: 24230154
Share

Originally posted by cafa ↑

' Those holding are the ones who are going to be burned. Pretty terrible announcement, really.'

Demon, for OS who claims to understand stats, and the P values, but gets it so wrong how do you come to the above conclusion?

HC is full of inspired advice on want share that drops a few % on news, but where is your analysis of HCC, the problems in treating end stage pts, and the clinical aspects of same?

You would know of course that SOR has been around for ten years, and it that time despite many hundreds of millions in World wide research nothing has come close to taking SOR from its place in 3rd line treatment.

For SIRT to obtain the same, 9.9 mths, OS in pts that were treated allows for a serious marketing push in all markets except the US. Even in the US one-to-one conversations with oncologists will occur and the data presented. The sales staff have just been given a very nice tool, albeit not as good as we may have hoped for.

Expand

cafa well said, hold SRX for 3 years and the SP will well over $50 as a minimum as the SRX business grows from this and other results due out in a few months.

SRX Price at posting: $15.45 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

RSG

HotCopper reacts as Resolute Mining told to pay US$160M if it wants its CEO back

HAS

Yangibana 33% complete says Hastings, as it provides clarification on funding

RCE

Recce scores $6.75M R&D rebate

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BIO

Biome reaches intellectual property milestone in strain development program

First 30 Last

Add SRX (ASX) to my watchlist